Brind.
  1. SeaStar Medical filed a registration statement with the SEC on August 1, 2025, with H.C. Wainwright & Co. serving as the exclusive placement agent.

SeaStar Medical submitted a premarket approval application to the FDA and discussed trial enrollment plans.

1 report, 1 independent Updated Wed 00:00
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

SeaStar Medical submitted a premarket approval application to the FDA and discussed trial enrollment plans.

Who's involved

What this event is mainly about
Food and Drug Administration

Keep exploring

Part of

SeaStar Medical filed a registration statement with the SEC on August 1, 2025, with H.C. Wainwright & Co. serving as the exclusive placement agent. All 1 developments

The entities involved

Coverage

Newest first; wire copies grouped